Desired Outcomes

• Reducing or eliminating obstructive and irritative voiding symptoms. An improvement in the AUA Symptom Score should be observed. Drug treatment with an a-adrenergic antagonist or 5a-reductase inhibitor is expected to reduce the AUA Symptom Score by 30% to 50%, improve peak and mean urinary flow rate by 1 to 3 mL/s, and decrease PVR to normal (less than 50 mL total) when compared to pre-treatment baseline values. The AUA Symptom Score may not correlate with response to therapy.

• Slowing disease progression. When compared to baseline, symptoms and serum BUN and creatinine should improve, stabilize, or decrease to the normal range with treatment.

• Preventing disease complications and reducing the need for surgical intervention.

• Avoiding or minimizing adverse treatment effects.

• Providing economical therapy.

• Maintaining or improving quality of life.

Table 52-1 Questions to Determine the AUA Symptom Score

Directions for the patient: The patient should be asked to respond to each question based on the absence or presence of symptoms over the past month. For each question, the patient can respond using a 1-5 scale, where 0 = not at all or none; 1 = less than 1 time in 5; 2 = less than half of the time; 3 = about half of the time; 4 = more than half of the time; and 5 = almost always

Directions for the clinician: After the patient completes the questionnaire, the scores for individual items should be tallied for a final score. Scores of 0-7 = mild symptoms; scores of 8-19 = moderate symptoms; scores more than 20 = severe symptoms

How To Deal With Rosacea and Eczema

How To Deal With Rosacea and Eczema

Rosacea and Eczema are two skin conditions that are fairly commonly found throughout the world. Each of them is characterized by different features, and can be both discomfiting as well as result in undesirable appearance features. In a nutshell, theyre problems that many would want to deal with.

Get My Free Ebook

Post a comment